Document:

mhr_8k-ex401.htm

    Exhibit 4.1

    
 

    MAGNUM
HUNTER RESOURCES CORPORATION

    

    COMMON
STOCK PURCHASE WARRANT

    

    
      	
              Initial
      Holder:  [                     ]

            	 
      	
              Original
      Issue Date: November ___, 2009

            
	 
      	
              No.
      of Shares Subject to Warrant:
      [            ]

            
	 
      	
              Exercise
      Price Per Share: $2.50

            
	 
      	
              Expiration
      Time: 5:00 p.m., Texas
      time, on November 16, 2012 (subject to acceleration as provided
      herein)

            
	 
      

    

    

    Magnum Hunter Resources Corporation, a
Delaware corporation (the “Company”), hereby certifies
that, for value received, the initial holder shown above (the “Initial Holder”), or its
permitted registered assigns (the “Holder”), is entitled to
purchase from the Company up to the number of shares of its common stock shown
above (the “Common
Stock”) (each such share, a “Warrant Share” and all such
shares, the “Warrant
Shares”) at the exercise price shown above (as may be adjusted from time
to time as provided herein, the “Exercise Price”), at any time,
and from time to time, after May 17, 2010 (the “Original Exercise Date”), and
through and including the expiration time shown above (the “Expiration Time”), and subject
to the following terms and conditions:

    

    This
Warrant is being issued pursuant to a Subscription Agreement, dated November 16,
2009 (the “Subscription
Agreement”), by and between the Company and the Initial
Holder.

    

     

     

     

     

     

     

     

     

     

     

     

    

    
      
        
           

        

        
          
          

          
            

          

        

        
           

        

      

    

    

    1.
            Definitions.  In
addition to the terms defined elsewhere in this Warrant, capitalized terms that
are not otherwise defined herein have the meanings given to such terms in the
Subscription Agreement.

    

    2.            
List of Warrant
Holders.  The Company shall register this Warrant, upon records to
be maintained by the Company for that purpose (the “Warrant Register”), in the
name of the record Holder (which shall include the Initial Holder or, as the
case may be, any registered assignee to which this Warrant is permissibly
assigned hereunder from time to time).  The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose
of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.

    

    3.
            List of Transfers;
Restrictions on Transfer. The Company shall register any transfer of all
or any portion of this Warrant in the Warrant Register, upon surrender of this
Warrant, with the Form of Assignment attached hereto duly completed and signed,
to the Company at its address specified herein. Upon any such registration or
transfer, a new Warrant to purchase Common Stock, in substantially the form of
this Warrant (any such new Warrant, a “New Warrant”), evidencing the
portion of this Warrant so transferred shall be issued to the transferee and a
New Warrant evidencing the remaining portion of this Warrant not so transferred,
if any, shall be issued to the transferring Holder.  The acceptance of
the New Warrant by the transferee thereof shall be deemed the acceptance by such
transferee of all of the rights and obligations in respect of the New Warrant
that the Holder has in respect of this Warrant.

    

    4.
            Exercise and Duration of
Warrant.

    

    (a)
         All or any part of this Warrant
shall be exercisable by the registered Holder as set forth in Section 10 of
this Warrant at any time and from time to time on or after the Original Exercise
Date and through and including the Expiration Time. Subject to Section 11
hereof, at the Expiration Time, the portion of this Warrant not exercised prior
thereto shall be and become void and of no value and this Warrant shall be
terminated and shall no longer be outstanding.

    

    (b)          
The Holder may exercise this Warrant by delivering to the Company (i) an
exercise notice, in the form attached hereto (the “Exercise Notice”), completed
and duly signed, and (ii) payment of the Exercise Price for the number of
Warrant Shares as to which this Warrant is being exercised.  The date such
items are delivered to the Company (as determined in accordance with the notice
provisions hereof) is an “Exercise Date.”  The
Holder shall not be required to deliver the original Warrant in order to effect
an exercise hereunder, but if it is not so delivered then such exercise shall
constitute an agreement by the Holder to deliver the original Warrant to the
Company as soon as practicable thereafter.  Execution and delivery of the
Exercise Notice shall have the same effect as cancellation of the original
Warrant and issuance of a New Warrant evidencing the right to purchase the
remaining number of Warrant Shares.

    

    (c)          
The Company will not close its stockholder books or records in any manner which
prevents the timely exercise of this Warrant pursuant to the terms
hereof.

    

    
      
        
           

        

        
          - 2
-

          
            

          

        

        
           

        

      

    

     

    

    (d)
           Cashless
Exercise.  Notwithstanding anything contained herein to the
contrary, the Holder may, in the event the Registration Statement, or a suitable
replacement, is not effective (exclusive of any Blackout Period imposed by the
Company pursuant to Paragraph 3 of the Subscription Agreement), exercise
this Warrant in whole or in part and, in lieu of making the cash payment
otherwise contemplated to be made to the Company upon such exercise in payment
of the Aggregate Exercise Price, elect instead to receive upon such exercise the
"Net Number" of shares of Common Stock determined according to the following
formula (a "Cashless
Exercise"):

    

    
      	
              Net
      Number =

            	
              (A x B) - (A x C)

              B

            

    

    

    For purposes of the foregoing
formula:

     

    A = the
total number of shares with respect to which this Warrant is then being
exercised.

     

    B = the
Weighted Average Price of the shares of Common Stock (as reported by Bloomberg)
for the five (5) consecutive Trading Days ending on the date immediately
preceding the date of the Exercise Notice.

     

    C = the
Exercise Price then in effect for the applicable Warrant Shares at the time of
such exercise.

     

    5.
           Delivery of Warrant
Shares.

    

    (a)
          Upon exercise of this
Warrant the Company shall promptly (but in no event later than three (3) Trading
Days after the Exercise Date) issue or cause to be issued and cause to be
delivered to or upon the written order of the Holder and in such name or names
as the Holder may designate, a certificate for the Warrant Shares issuable upon
such exercise, free of restrictive legends.  “Trading Day” shall mean a date
on which the Company’s Common Stock trades on its principal trading
market.  The Holder, or any Person permissibly so designated by the
Holder to receive Warrant Shares, shall be deemed to have become the holder of
record of such Warrant Shares as of the Exercise Date.  The Company shall,
upon the written request of the Holder, use its commercially reasonable efforts
to deliver, or cause to be delivered, Warrant Shares hereunder electronically
through the Depository Trust and Clearing Corporation or another established
clearing corporation performing similar functions, if available; provided, that, the Company
may, but will not be required to, change its transfer agent if its current
transfer agent cannot deliver Warrant Shares electronically through the
Depository Trust and Clearing Corporation.  If as of the time of exercise
the Warrant Shares constitute restricted or control securities, the Holder, by
exercising, agrees not to resell them except in compliance with all applicable
securities laws.

    

    

    
      
        
           

        

        
          - 3
-

          
            

          

        

        
           

        

      

    

    

    (b)
          To the extent permitted
by law, the Company’s obligations to issue and deliver Warrant Shares in
accordance with the terms hereof are absolute and unconditional, irrespective of
any action or inaction by the Holder to enforce the same, any waiver or consent
with respect to any provision hereof, the recovery of any judgment against any
Person or any action to enforce the same, or any setoff, counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by the
Holder or any other Person of any obligation to the Company or any violation or
alleged violation of law by the Holder or any other Person, and irrespective of
any other circumstance that might otherwise limit such obligation of the Company
to the Holder in connection with the issuance of Warrant
Shares.  Nothing herein shall limit a Holder’s right to pursue any
other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with
respect to the Company’s failure to timely deliver certificates representing
shares of Common Stock upon exercise of the Warrant as required pursuant to the
terms hereof.

    

    (c)
          If the Company fails to
cause its transfer agent to transmit to the Holder a certificate or the
certificates (either physical or electronic) representing the Warrant Shares
pursuant to the terms hereof by applicable delivery date, then, the Holder will
have the right to rescind such exercise.

    

    6.
            Charges, Taxes and
Expenses. Issuance and delivery of certificates for shares of Common
Stock upon exercise of this Warrant shall be made without charge to the Holder
for any issue or transfer tax, withholding tax, transfer agent fee or other
incidental tax or expense in respect of the issuance of such certificates, all
of which taxes and expenses shall be paid by the Company; provided, however, that the
Company shall not be required to pay any tax that may be payable in respect of
any transfer involved in the registration of any certificates for Warrant Shares
or the Warrants in a name other than that of the Holder. The Holder shall be
responsible for all other tax liability that may arise as a result of holding or
transferring this Warrant or receiving Warrant Shares upon exercise
hereof.

    

    7.
            Replacement of
Warrant.  If this Warrant is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for
and upon cancellation hereof, or in lieu of and substitution for this Warrant, a
New Warrant, but only upon receipt of evidence reasonably satisfactory to the
Company of such loss, theft or destruction and customary and reasonable
indemnity, if requested. Applicants for a New Warrant under such circumstances
shall also comply with such other reasonable regulations and procedures and pay
such other reasonable third-party costs as the Company may prescribe. If a New
Warrant is requested as a result of a mutilation of this Warrant, then the
Holder shall deliver such mutilated Warrant to the Company as a condition
precedent to the Company’s obligation to issue the New Warrant.

    

    8.
            Reservation of Warrant
Shares. The Company covenants that it will at all times reserve and keep
available out of the aggregate of its authorized but unissued and otherwise
unreserved Common Stock, solely for the purpose of enabling it to issue Warrant
Shares upon exercise of this Warrant as herein provided, the number of Warrant
Shares that are then issuable and deliverable upon the exercise of this entire
Warrant, free from preemptive rights or any other contingent purchase rights of
persons other than the Holder (taking into account the adjustments and
restrictions of Section 9). The Company covenants that all Warrant Shares so
issuable and deliverable shall, upon issuance and the payment of the applicable
Exercise Price in accordance with the terms hereof, be duly and validly
authorized, issued and fully paid and nonassessable.

    

    
      
        
           

        

        
          - 4
-

          
            

          

        

        
           

        

      

    

    

    

    9.
            Certain Adjustments;
Termination Under Certain Circumstances. The Exercise Price and number of
Warrant Shares issuable upon exercise of this Warrant are subject to adjustment
from time to time as set forth in this Section 9.

    

    (a)          
Stock Dividends and
Splits. If the Company, at any time while this Warrant is outstanding:
(i) pays a stock dividend on its Common Stock or otherwise makes a distribution
on any class of capital stock that is payable in shares of Common Stock, (ii)
subdivides outstanding shares of Common Stock into a larger number of shares, or
(iii) combines outstanding shares of Common Stock into a smaller number of
shares, then in each such case the Exercise Price shall be multiplied by a
fraction of which the numerator shall be the number of shares of Common Stock
outstanding immediately before such event and of which the denominator shall be
the number of shares of Common Stock outstanding immediately after such event.
Any adjustment made pursuant to clause (i) of this paragraph shall become
effective immediately after the record date for the determination of
stockholders entitled to receive such dividend or distribution, and any
adjustment pursuant to clause (ii) or (iii) of this paragraph shall become
effective immediately after the effective date of such subdivision or
combination.

    

    (b)
          Pro Rata
Distributions.  If the Company, at any time while this Warrant is
outstanding, distributes to all holders of Common Stock for no consideration:
(i) evidences of its indebtedness, (ii) any security (other than a distribution
of Common Stock covered by the preceding paragraph), (iii) rights or warrants to
subscribe for or purchase any security, or (iv) any other asset besides cash (in
each case, “Distributed
Property”), then either upon any exercise of this Warrant that occurs
after the record date fixed for determination of stockholders entitled to
receive such distribution or, at the option of the Company, concurrently with
such distribution, the Holder shall be entitled to receive, in addition to the
Warrant Shares otherwise issuable upon such exercise (if applicable), the
Distributed Property that such Holder would have been entitled to receive in
respect of such number of Warrant Shares had the Holder been the record holder
of such Warrant Shares immediately prior to such record date.

    

    (c)          
Fundamental
Transactions. As used herein, “Fundamental Transaction” means
at any time while this Warrant is outstanding: (i) the Company effects any
merger of the Company with another Person, in which the shareholders of the
Company immediately prior to the transaction own immediately after the
transaction less than a majority of the outstanding stock of the successor
entity, or its parent if applicable, (ii) the Company effects any sale of all or
substantially all of its assets in one or a series of related transactions,
(iii) any tender offer or exchange offer approved or authorized by the Company’s
Board of Directors is completed pursuant to which holders of at least a majority
of the outstanding Common Stock tender or exchange their shares for other
securities, cash or property, or (iv) the Company effects any reclassification
of the Common Stock or any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property.  In the event of a Fundamental Transaction pursuant
to which the securities, cash or property issuable with respect to the
outstanding Common Stock consist solely of cash and/or securities traded on a
national securities exchange or an established over-the-counter market (the
“Alternate
Consideration”), this Warrant shall expire immediately prior to the
closing of the Fundamental Transaction.  The Company shall not effect
any such Fundamental Transaction unless prior to or simultaneously with the
consummation thereof, any successor to the Company, surviving entity or the
corporation purchasing or otherwise acquiring such assets or other appropriate
corporation or entity shall assume the obligation to deliver to the Holder, such
Alternate Consideration as, in accordance with the foregoing provisions, the
Holder shall be entitled to receive upon proper exercise of this Warrant prior
to such closing.  In the event of a Fundamental Transaction in which
the consideration does not entirely consist of the Alternate Consideration, the
Company (or the successor entity) shall purchase this Warrant from the Holder by
paying to the Holder, within ten (10) Business Days after the closing of such
Fundamental Transaction cash in an amount equal to the Black Scholes Value (as
reasonably determined by the Board of Directors of the Company or the Company’s
financial advisor in the Fundamental Transaction) of the remaining unexercised
portion of this Warrant on the date of such Fundamental Transaction determined
as of the day of closing of the applicable Fundamental Transaction.

    

    
      
        
           

        

        
          - 5
-

          
            

          

        

        
           

        

      

    

    

    

    (d)
          Number of Warrant
Shares.  Simultaneously with any adjustment to the Exercise
Price pursuant to paragraph (a) of this Section 9, the number of Warrant Shares
that may be purchased upon exercise of this Warrant shall be increased or
decreased proportionately, so that after such adjustment the aggregate Exercise
Price payable hereunder for the adjusted number of Warrant Shares shall be the
same as the aggregate Exercise Price in effect immediately prior to such
adjustment.

    

    (e)
          Calculations. All
calculations under this Section 9 shall be made to the nearest cent or the
nearest 1/100th of a share, as applicable. The number of shares of Common Stock
outstanding at any given time shall not include shares owned or held by or for
the account of the Company, and the disposition of any such shares shall be
considered an issue or sale of Common Stock.

    

    (f)
          Notice of
Adjustments. Upon the occurrence of each adjustment pursuant to this
Section 9, the Company at its expense will, at the written request of the
Holder, promptly compute such adjustment in accordance with the terms of this
Warrant and prepare a certificate setting forth such adjustment, in good faith,
including a statement of the adjusted Exercise Price and adjusted number or type
of Warrant Shares or other securities issuable upon exercise of this Warrant (as
applicable), describing the transactions giving rise to such adjustments and
showing in detail the facts upon which such adjustment is based. Upon written
request, the Company will promptly deliver a copy of each such certificate to
the Holder and to the Company’s transfer agent for the Common
Stock.

    

    (g)
          Notice of Corporate
Events. If, while this Warrant is outstanding, the Company (i) declares a
dividend or any other distribution of cash, securities or other property in
respect of its Common Stock, including without limitation any granting of rights
or warrants to subscribe for or purchase any capital stock of the Company or any
Subsidiary, (ii) authorizes or approves, enters into any agreement contemplating
or solicits stockholder approval for any Fundamental Transaction or (iii)
authorizes the voluntary dissolution, liquidation or winding up of the affairs
of the Company, then, except if such notice and the contents thereof shall be
deemed to constitute material non-public information, the Company shall deliver
to the Holder a notice describing the material terms and conditions of such
transaction at least ten (10) Trading Days prior to the applicable record or
effective date on which a Person would need to hold Common Stock in order to
participate in or vote with respect to such transaction, and the Company will
take all reasonable steps to give Holder the practical opportunity to exercise
this Warrant prior to such time; provided, however, that the
failure to deliver such notice or any defect therein shall not affect the
validity of the corporate action required to be described in such
notice.

    

    
      
        
           

        

        
          - 6
-

          
            

          

        

        
           

        

      

    

    

    

    10.
          Payment of Exercise
Price.  The Holder shall pay the Exercise Price by delivery of
an Exercise Notice, together with immediately available funds, to an account
designated by the Company.

    

    11.
          Redemption by the
Company.  This Warrant may be redeemed by the Company for $0.01
per Warrant Share on no less than five (5) days Trading Days written notice to
the Holder if the average trading price of the Company’s Common Stock as traded
or quoted on the applicable Trading Market equals or exceeds $3.75 for twenty
(20) days in any consecutive thirty (30) day period prior to the Expiration
Time.

    

    12.          No Fractional Shares.
No fractional Warrant Shares will be issued in connection with any exercise of
this Warrant. In lieu of any fractional shares that would otherwise be issuable,
the Company shall pay cash equal to the product of such fraction multiplied by
the closing price of one Warrant Share as reported by the applicable Trading
Market on the Exercise Date.

    

    13.          Notices.  Any
and all notices or other communications or deliveries hereunder (including,
without limitation, any Exercise Notice) shall be delivered in accordance with
the procedures set forth in Section 6 of Annex I to the Subscription
Agreement.

    

    14.          Warrant Agent. The
Company shall serve as warrant agent under this Warrant. Upon thirty (30) days’
notice to the Holder, the Company may appoint a new warrant agent. Any
corporation into which the Company or any new warrant agent may be merged or any
corporation resulting from any consolidation to which the Company or any new
warrant agent shall be a party or any corporation to which the Company or any
new warrant agent transfers substantially all of its assets or its corporate
trust or shareholders services business shall be a successor warrant agent under
this Warrant without any further act. Any such successor warrant agent shall
promptly cause notice of its succession as warrant agent to be mailed (by first
class mail, postage prepaid) to the Holder at the Holder’s last address as shown
on the Warrant Register.

    

    15.
          Miscellaneous.

    

    (a)
          This Warrant shall be
binding on and inure to the benefit of the parties hereto and their respective
successors and assigns. Subject to the preceding sentence, nothing in this
Warrant shall be construed to give to any Person other than the Company and the
Holder any legal or equitable right, remedy or cause of action under this
Warrant.  This Warrant may be amended only in writing signed by the
Company and the Holder, or their successors and assigns.

    

    
      
        
           

        

        
          - 7
-

          
            

          

        

        
           

        

      

    

    

    

    (b)         
All questions concerning the construction, validity, enforcement and
interpretation of this Warrant shall be governed by and construed and enforced
in accordance with the internal laws of the State of New York, without regard to
the principles of conflicts of law thereof.

    

    (c)
          The headings herein are
for convenience only, do not constitute a part of this Warrant and shall not be
deemed to limit or affect any of the provisions hereof.

    

    (d)         
In case any one or more of the provisions of this Warrant shall be invalid or
unenforceable in any respect, the validity and enforceability of the remaining
terms and provisions of this Warrant shall not in any way be affected or
impaired thereby and the parties will attempt in good faith to agree upon a
valid and enforceable provision which shall be a commercially reasonable
substitute therefor, and upon so agreeing, shall incorporate such substitute
provision in this Warrant.

    

    (e)
          Prior to exercise of this
Warrant, the Holder hereof shall not, by reason of being a Holder, be entitled
to any rights of a stockholder with respect to the Warrant Shares.

    

    (f)
          No provision hereof, in
the absence of any affirmative action by Holder to exercise this Warrant to
purchase Warrant Shares, and no enumeration herein of the rights or privileges
of Holder, shall give rise to any liability of Holder for the purchase price of
any Common Stock or as a stockholder of the Company, whether such liability is
asserted by the Company or by creditors of the Company.

    

    

    

    [Signature
Page Follows]

    

    
      
        
           

        

        
          - 8
-

          
            

          

        

        
           

        

      

    

    

    IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its
authorized officer as of the date first indicated above.

    

    

     

    
      	 	
              MAGNUM
      HUNTER RESOURCES CORPORATION

              

              

              

              By:
      _________________________________

                    Name:

                    Title:

            

    

     

    

     

     

     

     

     

     

     

     

     

     

    

    
      
        
           

        

        
          - 9
-

          
            

          

        

        
           

        

      

    

    

    MAGNUM
HUNTER RESOURCES CORPORATION

    

    EXERCISE
NOTICE

    

    WARRANT
ORIGINALLY ISSUED NOVEMBER 16, 2009

    

    Ladies
and Gentlemen:

    

    (1)          
The undersigned hereby elects to exercise the above-referenced Warrant with
respect to
[                          ]
shares of Common Stock.  Capitalized terms used herein and not otherwise
defined herein have the respective meanings set forth in the
Warrant.

    

    (2)          
The payment of the Exercise Price shall be made in accordance with Section
10.

    

    (3)          
The holder shall pay the sum of $ ______________ to the Company in
accordance with the terms of the Warrant.

    

    (4)          
Pursuant to this Exercise Notice, the Company shall deliver to the Holder the
number of Warrant Shares determined in accordance with the terms of the
Warrant.

    

    
      	
              Dated:

            	 
      	 
      	
              HOLDER:

            
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	
              Print
      name

            
	 
      	 
      	 
      
	 
      	 
      	
              By:

            	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	
              Title:

            	 
      
	 
      	 
      	 
      	 
      

    

     

     

     

     

     

     

     

     

     

     

    
 

    
      
        
           

        

        
          - 10
-

          
            

          

        

        
           

        

      

    

    

    MAGNUM
HUNTER RESOURCES CORPORATION

    

    WARRANT
ORIGINALLY ISSUED NOVEMBER 16, 2009

    

    FORM OF
ASSIGNMENT

    To be
completed and signed only upon transfer of Warrant

    

    FOR VALUE
RECEIVED, the undersigned hereby sells, assigns and transfers unto
_________________ the right represented by the within Warrant to purchase
_________________ shares of Common Stock to which the within Warrant relates and
appoints __________________ as the undersigned’s attorney to transfer said right
on the books of the Company with full power of substitution in the
premises.

    

    
      	
              Dated:

            	 
      	 
      	
              TRANSFEROR:

            
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	
              Print
      name

            
	 
      	 
      	 
      
	 
      	 
      	
              By:

            	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	
              Title:

            	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	
              TRANSFEREE:

            
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	
              Print
      name

            
	 
      	 
      	 
      
	 
      	 
      	
              By:

            	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	
              Title:

            	 
      
	
              WITNESS:

            	 
      	 
      	 
      
	 
      	 
      	
              Address
      of Transferee:

            
	 
      	 
      	 
      	 
      
	
              Print
      name

            	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      

    

    

    

     

    

    

    
      
        
           

        

        
          - 11
-mhr_8k-ex1001.htm

    Exhibit 10.1

     

    

      SUBSCRIPTION
AGREEMENT

       

      

       

      Magnum
Hunter Resources Corporation

      777 Post
Oak Boulevard

      Suite
910

      Houston,
Texas  77056

      

      

      Gentlemen:

      

      The undersigned (the "Investor") hereby confirms its
agreement with Magnum Hunter Resources Corporation, a Delaware corporation (the
"Company"), as
follows:

       

      1.           This
Subscription Agreement, including the Terms and Conditions for Purchase of Units
attached hereto as Annex I
(collectively, this "Agreement"), is made as of the
date set forth below between the Company and the Investor.

       

      2.           The
Company represents and warrants that it has authorized the sale and issuance to
certain investors of up to an aggregate of _____________________________
(_,_00,000) units (the "Units"), each Unit consisting
of one share of its Common Stock, par value $_____ per share (the "Common Stock") and one-fifth
of a warrant to purchase one share of Common Stock (each whole warrant, a "Warrant"), subject to
adjustment by the Company's Board of Directors or a committee thereof, for a
purchase price of $_____ per share (the "Purchase Price").

       

      3.           The
Company represents and warrants that the offering and sale of the Units (the
"Offering") are being
made pursuant to (a) an effective Registration Statement on Form S-3
(Registration No. 33-161937) (the "Registration Statement") filed
by the Company with the Securities and Exchange Commission (the "Commission"), including the
Prospectus contained therein (the "Base Prospectus"), (b) if
applicable, certain "free writing prospectuses" (as that term is defined in Rule
405 under the Securities Act of 1933, as amended (the "Act")), that have been or will
be filed with the Commission and delivered to the Investor on or prior to the
date hereof (the "Issuer Free
Writing Prospectus"), containing certain supplemental information
regarding the Units, the terms of the Offering and the Company, and (c) a
Prospectus Supplement (the "Prospectus Supplement" and,
together with the Base Prospectus, the "Prospectus") containing
certain supplemental information regarding the Units and terms of the Offering
that has been or will be (i) filed with the Commission, and (ii) delivered to
the Investor (or made available to the Investor by the filing by the Company of
an electronic version thereof with the Commission).  The Company
further represents and warrants that it shall maintain the effectiveness of the
Registration Statement (or a suitable replacement) while any of the Warrants are
outstanding; provided, however, that the Company may suspend the use of the
Registration Statement for a period of not more than 30 days (a "Blackout Period") upon the
advice of counsel that such Blackout Period is necessary because of some
material non-public information in the Company's possession.

       

      4.           The
Company and the Investor agree that the Investor will purchase from the Company
and the Company will issue and sell to the Investor the Units set forth below
for the aggregate purchase price set forth below.  The Units shall be
purchased pursuant to the Terms and Conditions for Purchase of Units attached
hereto as Annex
I and incorporated herein by this reference as if fully set forth
herein.  The Investor acknowledges that the Offering is not being
underwritten by the placement agents (the "Placement Agents") named in
the Prospectus Supplement and that there is no minimum offering
amount.

       

      
        
           

        

        
          
          

          
            

          

        

        
           

        

      

      5.           The
manner of settlement of the Units purchased by the Investor shall be determined
by such Investor as follows (check
one):

       

      
        	
                [____]  
      A.

              	
                Delivery
      by crediting the account of the Investor's prime broker (as specified by
      such Investor on Exhibit A
      annexed hereto) with the Depository Trust Company ("DTC") through its
      Deposit/Withdrawal At Custodian ("DWAC") system, whereby
      Investor's prime broker shall initiate a DWAC transaction on the Closing
      Date using its DTC participant identification number, and released by
      Registrar and Transfer Company, the Company's transfer agent (the "Transfer Agent"), at the
      Company's direction.  NO LATER THAN ONE (1) BUSINESS
      DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY,
      THE INVESTOR SHALL:

              

      

       

      
        	
                 
      

              	
                (I)

              	
                DIRECT
      THE BROKER-DEALER AT WHICH THE ACCOUNT OR ACCOUNTS TO BE CREDITED WITH THE
      UNITS ARE MAINTAINED TO SET UP A DWAC INSTRUCTING THE TRANSFER AGENT TO
      CREDIT SUCH ACCOUNT OR ACCOUNTS WITH THE UNITS,
  AND

              

      

       

      
        
           

        

        
          - 2
-

          
            

          

        

        
           

        

      

      
        	
                 
      

              	
                (II)

              	
                REMIT
      BY WIRE TRANSFER THE AMOUNT OF FUNDS EQUAL TO THE AGGREGATE PURCHASE PRICE
      FOR THE UNITS BEING PURCHASED BY THE INVESTOR TO THE FOLLOWING
      ACCOUNT:

              

      

      

       

      Bank
Name: _____________

      ABA #
_____________

      Account
Name: Magnum Hunter Resources Corporation

      Account
Number: _____________

      F/C
Account: __________

       

      

       

      
         
– OR
–

      

       

      
        	
                [____]
      B.

              	
                Delivery
      versus payment ("DVP") through DTC (i.e., on the
      Closing Date, the Company shall deliver Units registered in the Investor's
      name and address as set forth below and released by the Transfer Agent to
      the Investor through DTC at the Closing directly to the account(s) at
      Canaccord Adams Inc. ("Canaccord") identified
      by the Investor; upon receipt of such Units, Canaccord shall promptly
      electronically deliver such Units to the Investor, and simultaneously
      therewith payment shall be made by Canaccord by wire transfer to the
      Company).  NO
      LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY
      THE INVESTOR AND THE COMPANY, THE INVESTOR
  SHALL:

              

      

       

      
        	
                 
      

              	
                (I)

              	
                NOTIFY CANACCORD OF THE ACCOUNT
      OR ACCOUNTS AT CANACCORD TO BE CREDITED WITH THE UNITS BEING PURCHASED BY
      SUCH INVESTOR, AND

              

      

       

       

      
        
          
          

        

        
          - 3
-

          
            

          

        

        
          
          

        

      

       

       

      
        	
                 
      

              	
                (II)

              	
                CONFIRM
      THAT THE ACCOUNT OR ACCOUNTS AT CANACCORD TO BE CREDITED WITH THE UNITS
      BEING PURCHASED BY THE INVESTOR HAVE A MINIMUM BALANCE EQUAL TO THE
      AGGREGATE PURCHASE PRICE FOR THE UNITS BEING PURCHASED BY THE
      INVESTOR.

              

      

       

      IT IS THE INVESTOR'S
RESPONSIBILITY TO (A) MAKE THE NECESSARY WIRE TRANSFER OR CONFIRM THE PROPER
ACCOUNT BALANCE IN A TIMELY MANNER AND (B) ARRANGE FOR SETTLEMENT BY WAY OF DWAC
OR DVP IN A TIMELY MANNER.  IF THE INVESTOR DOES NOT DELIVER THE
AGGREGATE PURCHASE PRICE FOR THE UNITS OR DOES NOT MAKE PROPER ARRANGEMENTS FOR
SETTLEMENT IN A TIMELY MANNER, THE UNITS MAY NOT BE DELIVERED AT CLOSING TO THE
INVESTOR OR THE INVESTOR MAY BE EXCLUDED FROM THE CLOSING
ALTOGETHER.

       

      6.           The
Investor represents that, except as set forth below, (a) it has had no material
relationship (exclusive of any investments by the Investor in the Company's
securities) within the past three years with the Company or persons known to it
to be affiliates of the Company, (b) it is not a FINRA member or an Associated
Person of a FINRA member (as such term is defined under the NASD Membership and
Registration Rules Section 1011) as of the Closing, and (c) neither the Investor
nor any group of Investors (as identified in a public filing made with the
Commission) of which the Investor is a part in connection with the Offering of
the Units, acquired, or obtained the right to acquire, 20% or more of the Common
Stock (or securities convertible into or exercisable for Common Stock) or the
voting power of the Company on a post-transaction
basis.  Exceptions:

       

      The representations above
are made to the knowledge of the signatory below.

      (If no
exceptions, write "none." If left blank, response will be deemed to be
"none.")

       

      7.           The
Investor represents that it has received (or otherwise had made available to it
by the filing by the Company of an electronic version thereof with the
Commission) the Base Prospectus which is a part of the Company's Registration
Statement, the documents incorporated by reference therein and any Issuer Free
Writing Prospectus (collectively, the "Disclosure Package"), prior to
or in connection with the receipt of this Agreement.  The Investor
acknowledges that, prior to the delivery of this Agreement by the Investor to
the Company, the Investor will receive certain additional information regarding
the Offering, including pricing information (the "Offering Information"). Such
information may be provided to the Investor by any means permitted under the
Act, including the Prospectus Supplement, a free writing prospectus and oral
communications.

       

      8.           No
offer by the Investor to buy Units will be accepted and no part of the Purchase
Price will be delivered to the Company until the Investor has received the
Offering Information and the Company has accepted such offer by countersigning a
copy of this Agreement, and any such offer may be withdrawn or revoked, without
obligation or commitment of any kind, at any time prior to the Company (or
Placement Agents on behalf of the Company) sending (orally, in writing or by
electronic mail) notice of its acceptance of such offer.  An
indication of interest will involve no obligation or commitment of any kind
until the Investor has been delivered the Offering Information and this
Agreement is accepted and countersigned by or on behalf of the
Company.

       

      

      [Remainder
of Page Left Blank Intentionally.  Signature Page
Follows.]

       

      
        
           

        

        
          - 4
-

          
            

          

        

        
           

        

      

      

       

       

      Number of
Units: ___________________

       

      Purchase
Price Per Unit: $ ____________

       

      Aggregate
Purchase Price: $ __________

      

       

      Please confirm that the foregoing
correctly sets forth the agreement between us by signing in the space provided
below for that purpose.

       

      

       

      

       

      
        	 	
                Dated
      as of:  ______________ __, 2009

                 

                 

                ___________________________
      _________

                INVESTOR

                 

                By:                                 
                            
                             

                Print
      Name:                                      
                                

                Title:                                                              
                    

                Address:                                           
                               

                 

                
________________________
      ____________

                 

                E-mail:

                Phone:                                                                         
      

              

      

       

                                                                 

       

      

      

      Agreed
and Accepted

      this ___
day of ______________, 2009:

      

       

      MAGNUM
HUNTER RESOURCES CORPORATION

       

      

      By:                                                                

      Name:

      Title:

       

      
        
           

        

        
          - 5
-

          
            

          

        

        
           

        

      

      ANNEX I

       

      TERMS
AND CONDITIONS FOR PURCHASE OF UNITS

       

      1.           Authorization and Sale of the
Units.  Subject to the terms and conditions of this Agreement,
the Company has authorized the sale of the Units.

       

      2.           Agreement
to Sell and Purchase the Units; Placement Agents.

       

      2.1           At
the Closing (as defined in Section 3.1), the
Company will sell to the Investor, and the Investor will purchase from the
Company, upon the terms and conditions set forth herein, the number of Units set
forth on the last page of the Agreement to which these Terms and Conditions for
Purchase of Units are attached as Annex I (the "Signature Page") for the
aggregate purchase price therefor set forth on the Signature Page.

       

      2.2           The
Company proposes to enter into substantially this same form of Subscription
Agreement with certain other investors (the "Other Investors") and expects
to complete sales of Units to them.  The Investor and the Other
Investors, if any, are hereinafter sometimes collectively referred to as the
"Investors," and this
Agreement and the Subscription Agreements executed by the Other Investors are
hereinafter sometimes collectively referred to as the "Agreements."

      

      2.3           Investor
acknowledges that the Company has agreed to pay Canaccord Adams Inc. ("Canaccord") (the "Placement Agent") a fee (the
"Placement Fee") in
respect of the sale of Units to the Investor.

      

      2.4           The
Company has entered into a Placement Agency Agreement, dated November ___, 2009
(the "Placement
Agreement"), with the Placement Agent that contains certain
representations, warranties, covenants and agreements of the Company that may be
relied upon by the Investor, which shall be a third party beneficiary
thereof.  The Company represents and warrants that a true and correct
copy of the Placement Agreement is attached hereto as Exhibit
B.  Except with respect to the material terms and conditions of
the transactions contemplated by this Agreement, the Placement Agreement and any
other documents or agreements contemplated hereby or thereby, the Company
confirms that neither it nor any other person acting on its behalf has provided
the Investor or any Other Investor or its respective agents or counsel with any
information that constitutes or could reasonably be expected to constitute
material, non-public information.   The Company understands and
confirms that the Investor will rely on the foregoing representations in
effecting transactions in securities of the Company.

      

      3.           Closings
and Delivery of the Units and Funds.

       

      3.1           Closing.  The completion of
the purchase and sale of the Units (the "Closing") shall occur at a
place and time (the "Closing
Date") to be specified by the Company and the Placement Agent (such
Closing Date to be the third business day following the date of this signed
Agreement), and of which the Investors will be notified in advance by the
Placement Agent, in accordance with Rule 15c6-1 promulgated under the Securities
Exchange Act of 1934, as amended (the "Exchange Act").  At
the Closing, (a) the Company shall cause to be delivered to the Investor the
number of Units set forth on the Signature Page registered in the name of the
Investor or, if so indicated on the Investor Questionnaire attached hereto as
Exhibit A, in
the name of a nominee designated by the Investor and (b) the aggregate purchase
price for the Units being purchased by the Investor will be delivered by or on
behalf of the Investor to the Company.

       

      
        
           

        

        
          A-1

          
            

          

        

        
           

        

      

      3.2           Conditions to the
Obligations of the Parties.

      

      (a)          
Conditions
to the Company's Obligations.  The Company's
obligation to issue and sell the Units to the Investor shall be subject to: (i)
the delivery by the Investor, in accordance with the provisions of this
Agreement, of the purchase price for the Units being purchased hereunder as set
forth on the Signature Page and (ii) the accuracy of the representations and
warranties made by the Investor in this Agreement and the fulfillment of those
undertakings of the Investor in this Agreement to be fulfilled prior to the
Closing Date.

      

      (b)           Conditions
to the Investor's Obligations.  The Investor's
obligation to purchase the Units will be subject to (i) the delivery by the
Company of the Units in accordance with the provisions of this Agreement, (ii)
the accuracy of the representations and warranties made by the Company and the
fulfillment of those undertakings of the Company to be fulfilled prior to the
Closing Date, including without limitation, those contained in the Placement
Agreement, (iii) the satisfaction of the conditions to the closing set forth in
the Placement Agreement, and to the condition that Canaccord, as placement
agent, shall not have: (x) terminated the Placement Agreement pursuant to the
terms thereof or (y) determined that the conditions to the closing in the
Placement Agreement have not been satisfied.  The Investor's
obligations are expressly not conditioned on the purchase by any or all of the
Other Investors of the Units that they have agreed to purchase from the
Company.  The Investor understands and agrees that, in the event that
Canaccord, as lead placement agent, in its sole discretion determines that the
conditions to closing in the Placement Agreement have not been satisfied or if
the Placement Agreement may be terminated for any other reason permitted by the
Placement Agreement, then Canaccord, as lead placement agent, may, but shall not
be obligated to, terminate such Agreement, which shall have the effect of
terminating this Subscription Agreement pursuant to Section 14
below.

      

      3.3           Delivery
of Funds.

      

      (a)           DWAC
Delivery.  If the Investor elects to settle the Units purchased
by such Investor through DTC's Deposit/Withdrawal at Custodian ("DWAC") delivery system, no later
than one (1) business day after the execution of this Agreement by the Investor
and the Company, the Investor shall remit by wire transfer the amount of
funds equal to the aggregate purchase price for the Units being purchased by the
Investor to the following account designated by the Company:

      

       

      Bank
Name: ________________

      ABA #
_____________

      Account
Name: Magnum Hunter Resources Corporation

      Account
Number: __________

      F/C
Account: ___________

      

      Such
funds shall be held in escrow by the Company until the Closing upon the
satisfaction of the conditions set forth in Section 3.2(b)
hereof.

      
        
           

        

        
          A-2

          
            

          

        

        
           

        

      

      

      (b)           Delivery Versus Payment
through The Depository Trust Company.  If the Investor elects
to settle the Units purchased by such Investor by delivery versus payment
through DTC, no later
than one (1) business day after the execution of this Agreement by the Investor
and the Company, the Investor shall confirm that the account or accounts
at Canaccord to be credited with the Units being purchased by the Investor have
a minimum balance equal to the aggregate purchase price for the Units being
purchased by the Investor.

      

      3.4           Delivery
of Units.

      

      (a)           DWAC
Delivery.  If the Investor elects to settle the Units purchased
by such Investor through DTC's DWAC delivery system, no later
than one (1) business day after the execution of this Agreement by the Investor
and the Company, the Investor shall direct the broker-dealer at which the
account or accounts to be credited with the Units being purchased by such
Investor are maintained, which broker/dealer shall be a DTC participant, to set
up a DWAC instructing Registrar and Transfer Company, the Company's Transfer
Agent, to credit such account or accounts with the Units.  Such DWAC
instruction shall indicate the settlement date for the deposit of the Units,
which date shall be provided to the Investor by Canaccord.  At the
Closing, the Company shall direct the Transfer Agent to credit the Investor's
account or accounts with the Units pursuant to the information contained in the
DWAC.

      

      (b)           Delivery Versus Payment
through The Depository Trust Company.  If the Investor elects
to settle the Units purchased by such Investor by delivery versus payment
through DTC, no later
than one (1) business day after the execution of this Agreement by the Investor
and the Company, the Investor shall notify Canaccord of the account or
accounts at Canaccord to be credited with the Units being purchased by such
Investor.  On the Closing Date, the Company shall deliver the Units to
the Investor through DTC directly to the account(s) at Canaccord identified by
Investor and simultaneously therewith payment shall be made by Canaccord by wire
transfer to the Company.

      

      4.           Representations,
Warranties and Covenants of the Investor.

       

      The Investor acknowledges, represents
and warrants (as of the date hereof) to, and agrees with, the Company and the
Placement Agents that:

      

      4.1           The
Investor (a) is knowledgeable, sophisticated and experienced in making, and is
qualified to make decisions with respect to, investments in shares presenting an
investment decision like that involved in the purchase of the Units, including
investments in securities issued by the Company and investments in comparable
companies, (b) has answered all questions on the Signature Page and the Investor
Questionnaire and the answers thereto are true and correct as of the date hereof
and will be true and correct as of the Closing Date and (c) in connection with
its decision to purchase the number of Units set forth on the Signature Page,
has received and is relying only upon the Disclosure Package and the documents
incorporated by reference therein and the Offering Information and the
representations, warranties, covenants and agreements of the Company contained
in the Placement Agreement.

      
        
           

        

        
          A-3

          
            

          

        

        
           

        

      

      

      4.2          No
action has been or will be taken in any jurisdiction outside the United States
by the Company or the Placement Agents that would permit an offering of the
Units, or possession or distribution of offering materials in connection with
the issue of the Units in any jurisdiction outside the United States where
action for that purpose is required, (b) if the Investor is outside the United
States, it will comply with all applicable laws and regulations in each foreign
jurisdiction in which it purchases, offers, sells or delivers Units or has in
its possession or distributes any offering material, in all cases at its own
expense and (c) none of the Placement Agents is authorized to make or has made
any representation, disclosure or use of any information in connection with the
issue, placement, purchase and sale of the Units, except as set forth or
incorporated by reference in the Base Prospectus, any Issuer Free Writing
Prospectus or the Prospectus Supplement.

      

      4.3           The
Investor is either an individual or an entity duly organized, validly existing
and in good standing under the laws of the jurisdiction of its organization and
has full right, power, authority and capacity to enter into this Agreement and
to consummate the transactions contemplated hereby and has taken all necessary
action to authorize the execution, delivery and performance of this Agreement,
and (b) this Agreement constitutes a valid and binding obligation of the
Investor enforceable against the Investor in accordance with its terms, except
as enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors' and contracting
parties' rights generally and except as enforceability may be subject to general
principles of equity (regardless of whether such enforceability is considered in
a proceeding in equity or at law) and except as to the enforceability of any
rights to indemnification or contribution that may be violative of the public
policy underlying any law, rule or regulation (including any federal or state
securities law, rule or regulation).  The Investor's execution,
delivery and performance of this Agreement and the consummation by it of the
transactions contemplated hereby do not and will not (i) conflict with or
violate any provision of the Investor's certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Investor  is subject (including federal and
state securities laws and regulations), or by which any property or asset of the
Investor is bound or affected.

       

      4.4           The
Investor understands that nothing in this Agreement, the Prospectus or any other
materials presented to the Investor in connection with the purchase and sale of
the Units constitutes legal, tax or investment advice.  The Investor
has consulted such legal, tax and investment advisors and made such
investigation as it, in its sole discretion, has deemed necessary or appropriate
in connection with its purchase of Units.

       

      4.5           Since
the time at which a Placement Agent first contacted the Investor about the
Offering, the Investor has not disclosed any information regarding the Offering
to any third parties (other than its legal, accounting and other advisors) and
has not engaged in any transactions involving the securities of the Company
(including, without limitation, any Short Sales involving the Company's
securities).  The Investor covenants that it will (i) maintain the
confidentiality of all information acquired as a result of the transactions
contemplated herein and (ii) not engage in any purchases or sales of the
securities of the Company (including Short Sales), in each case prior to the
time that the transactions contemplated by this Agreement are publicly
disclosed.  The Investor agrees that it will not use any of the Units
acquired pursuant to this Agreement to cover any short position in the Common
Stock if doing so would be in violation of applicable securities
laws.  For purposes hereof, "Short Sales" include, without
limitation, all "short sales" as defined in Rule 200 promulgated under
Regulation SHO under the Exchange Act, whether or not against the box, and all
types of direct and indirect stock pledges, forward sales contracts, options,
puts, calls, short sales, swaps, "put equivalent positions" (as defined in Rule
16a-1(h) under the Exchange Act) and similar arrangements (including on a total
return basis), and sales and other transactions through non-US broker dealers or
foreign regulated brokers.

       

      
        
           

        

        
          A-4

          
            

          

        

        
           

        

      

      5.           Survival of Representations,
Warranties and Agreements; Third Party
Beneficiary.  Notwithstanding any investigation made by any
party to this Agreement or by the Placement Agents, all covenants, agreements,
representations and warranties made by the Company and the Investor herein and,
with respect to the Company, in the Placement Agreement, will survive the
execution of this Agreement, the delivery to the Investor of the Units being
purchased and the payment therefor.

       

      6.           Notices.  All
notices, requests, consents and other communications hereunder will be in
writing, will be mailed (a) if within the domestic United States by first-class
registered or certified airmail, or nationally recognized overnight express
courier, postage prepaid, or by facsimile or (b) if delivered from outside the
United States, by International Federal Express or facsimile, and (c) will be
deemed given (i) if delivered by first-class registered or certified mail
domestic, three business days after so mailed, (ii) if delivered by nationally
recognized overnight carrier, one business day after so mailed, (iii) if
delivered by International Federal Express, two business days after so mailed
and (iv) if delivered by facsimile, upon electric confirmation of receipt and
will be delivered and addressed as follows:

       

      
        	
                 
      

              	
                (a)

              	
                if to the Company,
      to:

                 

                
                  Magnum
      Hunter Resources Corporation

                  777
      Post Oak Boulevard

                  Suite
      910

                  Houston,
      Texas  77056

                  Attention:  General
      Counsel

                  Facsimile
      No.:  (832) 369-6992

                  

                   with copies
      to:

                  

                  Fulbright
      & Jaworski l.l.p.

                  2200
      Ross Avenue, Suite 2000

                  Dallas,
      Texas  75201

                  Attention:  David
      E. Morrison

                  Email:
      dmorrison@fulbright.com

                

              

      

       

      

      (b)         if
to the Investor, at its address on the Signature Page hereto, or at such other
address or addresses as may have been furnished to the Company in
writing.

       

      7.           Changes.  This
Agreement may not be modified or amended except pursuant to an instrument in
writing signed by the Company and the Investor.  Any modification or
amendment to Section 2 (Representations and Warranties of the Company), Section
5 (Conditions of Placement Agents' Obligations), Section 6(f) (Representations
and Agreements to Survive Delivery), or Section 10 (Persons Entitled to Benefit
of Agreement) of the Placement Agreement, and any modification or amendment to
the Placement Agreement that is material and adverse to the Investor, shall
require the prior written consent of the Investor.

       

      
        
           

        

        
          A-5

          
            

          

        

        
           

        

      

      

      8.           Headings.  The
headings of the various sections of this Agreement have been inserted for
convenience of reference only and will not be deemed to be part of this
Agreement.

       

      9.           Severability.  In
case any provision contained in this Agreement should be invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of the
remaining provisions contained herein will not in any way be affected or
impaired thereby.

       

      10.        Governing Law.  This
Agreement will be governed by, and construed in accordance with, the internal
laws of the State of New York, without giving effect to the principles of
conflicts of law that would require the application of the laws of any other
jurisdiction.  Except as set forth below, no proceeding may be
commenced, prosecuted or continued in any court other than the courts of State
of New York located in the City and County of New York or the United States
District Court for the Southern District of New York, which courts shall have
jurisdiction over the adjudication of such matters, and the parties hereby
consent to the jurisdiction of such courts and personal service with respect
thereto.  All parties hereby waive all right to trial by jury in any
proceeding (whether based upon contract, tort or otherwise) in any way arising
out of or relating to this Agreement.  All parties agree that a final
judgment in any such proceeding brought in any such court shall be conclusive
and binding upon each party and may be enforced in any other courts in the
jurisdiction of which a party is or may be subject, by suit upon such
judgment.

       

      11.        Counterparts.  This
Agreement may be executed in two or more counterparts, each of which will
constitute an original, but all of which, when taken together, will constitute
but one instrument, and will become effective when one or more counterparts have
been signed by each party hereto and delivered to the other
parties.  Delivery of an executed counterpart by facsimile or portable
document format (.pdf) shall be effective as delivery of a manually executed
counterpart thereof.

       

      12.        Confirmation of
Sale.  The Investor acknowledges and agrees that such
Investor's receipt of the Company's signed counterpart to this Agreement,
together with the Prospectus Supplement (or the filing by the Company of an
electronic version thereof with the Commission), shall constitute written
confirmation of the Company's sale of Units to such Investor.

       

      13.        Press Release.  The
Company and the Investor agree that, prior to the opening of the New York Stock
Exchange Amex Equities market in New York City on the business day immediately
after the date hereof, the Company shall (i) issue a press release announcing
the Offering and disclosing all material information regarding the Offering and
(ii) file a Current Report on Form 8-K with the Commission disclosing all
material information regarding the Offering and including the Placement
Agreement and a form of this Agreement as exhibits thereto.  From and
after the issuance of such press release and the filing of such Current Report
on Form 8-K, the Company shall have publicly disclosed all material, non-public
information delivered to any of the Investors by the Company or any person
acting on its behalf, including, without limitation, the Placement Agent, in
connection with the transactions contemplated by this Agreement, the Placement
Agreement and any other documents or agreements contemplated hereby or
thereby.  The Company shall not identify the name of any Investor or
any affiliate of any investment adviser of such Investor in any press release or
public filing, or otherwise publicly disclose the name of any Investor or any
affiliate of investment adviser of such Investor, without such Investor's prior
written consent, unless required by law or the rules and regulations of a
national securities exchange, provided, however, that, if permitted by
applicable law, regulation, legal or judicial process, promptly after becoming
aware of any request or requirement to so disclose (a "Disclosure Requirement"), and
in any event prior to any such disclosure, the Company will provide such
Investor with notice of such request or requirement so that such Investor may at
its election seek a protective order or other appropriate remedy and the Company
will fully cooperate with such Investor's efforts to obtain the same; provided,
further, however, if, absent the entry of such a protective order or other
remedy, the Company is compelled by applicable law, rule or regulation or a
court order, subpoena, similar judicial process, regulatory agency or stock
exchange rule to disclose such Investor's name, the Company may disclose only
that portion of such information that the Company is so compelled to disclose
and will use its reasonable efforts to obtain assurance that confidential
treatment will be accorded to that portion of such information that is being
disclosed.  As of the date hereof, the Company is not aware of any
Disclosure Requirement.

       

      
        
           

        

        
          A-6

          
            

          

        

        
           

        

      

      14.        Termination.  In the
event that the Placement Agreement is terminated by the Placement Agents
pursuant to the terms thereof, this Agreement shall terminate without any
further action on the part of the parties hereto.

       

      15.        Fees and
Expenses.  Each party shall pay the fees and expenses of its
advisers, counsel, accountants and other experts, if any, and all other expenses
incurred by such party incident to the negotiation, preparation, execution,
delivery and performance of this Agreement.

      

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

      
 

      
        
           

        

        
          A-7

          
            

          

        

        
           

        

      

      

      Exhibit
A

       

      MAGNUM
HUNTER RESOURCES CORPORATION

       

      INVESTOR
QUESTIONNAIRE

       

      Pursuant
to Section 3 of
Annex I to the
Agreement, please provide us with the following information:

       

      

      
        	1.	
                The
      exact name that your Units are to be registered in. You may use a nominee
      name if appropriate:

              	 
      
	2.	
                The
      relationship between the Investor and the registered holder listed in
      response to item 1 above:

              	 
      
	3.	
                The
      mailing address of the registered holder listed in response to item 1
      above:

              	 
      
	4.	
                The
      Social Security Number or Tax Identification Number of the registered
      holder listed in the response to item 1 above:

              	 
      
	5.	
                Name
      of DTC Participant (broker-dealer at which the account or accounts to be
      credited with the Units are maintained):

              	 
      
	6.	
                DTC
      Participant Number:

              	 
      
	7.	
                Name
      of Account at DTC Participant being credited with the
    Units:

              	 
      
	8.	
                Account
      Number at DTC Participant being credited with the Units:

              	 
      
	9.	
                EIN
      Number:

              	 
      

      

      

      

      
        
           

        

        
          A-8

          
            

          

        

        
           

        

      

      

       

      Exhibit
A

       

      PLACEMENT
AGENCY AGREEMENT

       

      

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

      
 

      
        
           

        

        
          A-9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}]]